Objective: To examine the relationship between the use of highly active antiretroviral treatment (HAART) and the occurrence of opportunistic illnesses (OIs) among children perinatally infected with human immunodeficiency virus.

Design: Prospective cohort study.

Setting: Pediatric AIDS Clinical Trials Group 219C cohort.

Participants: From September 15, 2000, to August 31, 2003, 1927 children perinatally infected with human immunodeficiency virus and receiving HAART were followed up. Main Exposures Age at initiating HAART, duration of HAART use, CD4+ T-lymphocyte percentage, and human immunodeficiency virus 1 viral load.

Main Outcome Measures: Incidence rates for Centers for Disease Control and Prevention OI category B and OI category C events were calculated. The association between main exposures and OI occurrence was estimated using proportional hazards regression.

Results: Of 1927 subjects, 226 (12.7%) developed OIs during follow-up. Incidence rates were 4.99 per 100 person-years (95% confidence interval, 4.30-5.76) for first OI category B events and 1.47 per 100 person-years (95% confidence interval, 1.12-1.91) for first OI category C events. Duration of HAART use was not related to OI risk. Older age (age >10 years) at HAART initiation was associated with increased risk of a first OI (hazard ratio, 2.48; 95% confidence interval, 1.23-5.00) compared with initiating HAART in children younger than 2 years. This increased risk diminished after adjusting for CD4+ T-lymphocyte percentage and Centers for Disease Control and Prevention disease category at HAART initiation. More children with OIs than without OIs had a CD4+ T-lymphocyte percentage of less than 15% at HAART initiation (49.6% of children with OIs vs 23.7% of children without OIs), at enrollment (41.2% of children with OIs vs 7.7% of children without OIs), and at the end of follow-up (41.2% of children with OIs vs 8.3% of children without OIs).

Conclusions: Opportunistic illnesses are occurring in the pediatric human immunodeficiency virus population in the HAART era, mainly in children with persistently low CD4+ T-lymphocyte percentages. Lack of a sustained response to HAART rather than age at or duration of HAART use is predictive of OI risk.

Download full-text PDF

Source
http://dx.doi.org/10.1001/archpedi.160.8.778DOI Listing

Publication Analysis

Top Keywords

children ois
24
human immunodeficiency
20
immunodeficiency virus
16
cd4+ t-lymphocyte
16
opportunistic illnesses
12
children
12
haart
12
duration haart
12
t-lymphocyte percentage
12
category events
12

Similar Publications

Germline inactivating mutations of the SLC25A1 gene contribute to various human disorders, including Velocardiofacial (VCFS), DiGeorge (DGS) syndromes and combined D/L-2-hydroxyglutaric aciduria (D/L-2HGA), a severe systemic disease characterized by the accumulation of 2-hydroxyglutaric acid (2HG). The mechanisms by which SLC25A1 loss leads to these syndromes remain largely unclear. Here, we describe a mouse model of SLC25A1 deficiency that mimics human VCFS/DGS and D/L-2HGA.

View Article and Find Full Text PDF

Polygenic risk scores (PRSs) have recently been used to inform reproductive decision-making in the context of embryonic screening. While this is yet to be widespread, it is contested and raises several challenges. This article provides an overview of some of the ethical considerations that arise with using PRSs for embryo screening and offers a series of regulatory considerations for jurisdictions that may wish to permit this in the future.

View Article and Find Full Text PDF

Introduction: The most common and severe cause of morbidity and mortality among HIV- positive children is opportunistic infections (OIs). All HIV-infected children are at risk of developing a variety of OIs. Healthcare workers, programmers, and other stakeholders are in doubt about using the onset and predictors of OIs among schoolchildren on antiretroviral therapy (ART) due to the presence of conflicting results found in the primary studies.

View Article and Find Full Text PDF
Article Synopsis
  • Opportunistic infections (OIs) are a serious risk for HIV-infected children in Ethiopia, even with advancements in antiretroviral therapy (ART), and this study aimed to assess their occurrence and predictive factors.
  • The research analyzed data from 409 HIV-infected children under 15 years, finding that 29.8% developed at least one OI, especially pulmonary tuberculosis, with an incidence rate of 12.8 per 100 person-years.
  • Significant predictors for OIs included not disclosing HIV status, age (particularly 10-14 years), lack of mother-to-child transmission prevention history, and low hemoglobin levels, highlighting the need for targeted interventions.
View Article and Find Full Text PDF

Incidence and predictors of common opportunistic infections among children living with HIV at Bahir Dar City, Ethiopia.

Sci Rep

October 2024

Department of Pediatrics and Child Health Nursing, School of Health Sciences, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.

Article Synopsis
  • Despite the effectiveness of antiretroviral therapy (ART) in reducing opportunistic infections (OIs), these infections continue to seriously affect children with HIV, particularly in low and middle-income countries like Ethiopia.
  • This study focuses on examining the incidence and predictors of common OIs among HIV-infected children receiving ART in Bahir Dar City through a retrospective cohort study involving 403 participants.
  • The findings revealed an overall incidence rate of 7.06 OIs per 100 person-years, with significant risk factors identified such as advanced WHO clinical stages and poor adherence to ART.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!